Clinical Trials Act 2011Section 10
10. Functions of Pharmacovigilance Committee
(1) The functions of the Pharmacovigilance Committee shall be to –
(a) collect all available information on adverse events and
adverse reactions, in Mauritius or elsewhere, particularly
in relation to subjects involved in clinical trials;
(b) analyse and classify any such information and
communicate it to the health personnel and to the public
and, where appropriate, to the relevant division of the
World Health Organisation;
(c) liaise with the Trade and Therapeutics Committee for the
purpose of recommending measures, by means of
legislation or otherwise, to minimise the risk of adverse
events and adverse reactions;
104 Acts 2011
(d) ensure that health personnel are given adequate training in
the collection and analysis of adverse events and adverse
reactions;
(e) depute any of its members, where it deems necessary, to
conduct an inspection in accordance with section 26;
(f) advise the Council and the Ethics Committee on any
matter specified in this section.
(2) The Pharmacovigilance Committee shall establish and follow its
own standard operating procedures.
PART V – TRIAL LICENCE